Skip To Main Content
Ying-Wen Su on Muck Rack

Ying-Wen Su

As seen in: MDPI, SAGE Publishing
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ying-Wen

Contact Ying-Wen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Combining KPNA2 and FOXM1 Expression as Prognostic Markers and Therapeutic Targets in Hormone Receptor-Positive, HER2-Negative Breast Cancer

|
By Chung-Hsin Tsai, Ying-Wen Su, Yuan-Ching Chang, Tsen-Long Yang
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Effects of Reishimmune-S, a Fungal Immunomodulatory Peptide Supplement, on the Quality of Life and Circulating Natural Killer Cell Profiles of Patients With Early Breast Cancer Receiving Adjuvant Endocrine Therapy - Ying-Wen Su, Wen-Yu Huang, Sheng-Hsiang

|
By Wen-Yu Huang, Sheng-Hsiang Lin, Po-Sheng Yang, Ying-Wen Su
| SAGE Publishing
Skip to main content Intended for healthcare professionals Introduction Hormone receptor (HR)-positive breast cancer (BC) is the most common type of BC, accounting for approximately 70% of all BC cases.
Open in Who Shared Issue with article?
See all 2 articles